Dhooria Sahajal, Aggarwal Ashutosh Nath, Singh Navneet, Gupta Dheeraj, Behera Digamber, Gupta Nalini, Agarwal Ritesh
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab and Haryana, India.
Department of Cytology, Postgraduate Institute of Medical Education and Research, Chandigarh, Punjab and Haryana, India.
Lung India. 2015 Jan-Feb;32(1):6-10. doi: 10.4103/0970-2113.148399.
Several studies have reported the performance of combining endoscopic ultrasound fine-needle aspiration with an echobronchoscope (EUS-B-FNA), with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), for the diagnosis of mediastinal lymphadenopathy. Herein we report our initial experience with this technique.
In this retrospective study, we report the outcome of patients who underwent EUS-B-FNA with or without EBUS-TBNA during the same session. Details of the lymph nodes sampled, number of passes, duration of the procedure, results of the cytological examination, and the final diagnosis of all the patients are presented.
Eleven patients underwent EUS-B-FNA during the study period. EUS-B-FNA and EBUS-TBNA together yielded a sensitivity and specificity of 72.7 and 100%, respectively. The number of lymph nodes sampled per patient and the number of passes per lymph node were significantly higher with EBUS-TBNA compared to EUS-B-FNA. The mean duration of procedure was also significantly higher in the EBUS-TBNA group. The most common reason (five patients (45.5%)) for resorting to EUS-B-FNA was the patient being unfit for EBUS-TBNA or the inability of the operator to complete the procedure. Sarcoidosis was the most frequent final diagnosis in the study patients (four cases), followed by bronchogenic carcinoma (three cases).
EUS-B-FNA is a useful additional tool for the diagnosis of mediastinal lymphadenopathy. In combination with EBUS-TBNA, it has a fairly good diagnostic yield and is a good alternative in situations where EBUS-TBNA is not feasible.
多项研究报道了将超声内镜引导下细针穿刺活检术与超声支气管镜(EUS-B-FNA)、支气管内超声引导下经支气管针吸活检术(EBUS-TBNA)联合用于纵隔淋巴结病诊断的情况。在此,我们报告我们在该技术方面的初步经验。
在这项回顾性研究中,我们报告了同期接受EUS-B-FNA(无论是否联合EBUS-TBNA)的患者的治疗结果。呈现了所取淋巴结的详细情况、穿刺次数、操作持续时间、细胞学检查结果以及所有患者的最终诊断。
在研究期间,11例患者接受了EUS-B-FNA。EUS-B-FNA与EBUS-TBNA联合应用时,敏感性和特异性分别为72.7%和100%。与EUS-B-FNA相比,EBUS-TBNA的每位患者取样淋巴结数量和每个淋巴结的穿刺次数显著更高。EBUS-TBNA组的平均操作持续时间也显著更长。采用EUS-B-FNA的最常见原因(5例患者(45.5%))是患者不适合EBUS-TBNA或操作者无法完成该操作。结节病是研究患者中最常见的最终诊断(4例),其次是支气管源性癌(3例)。
EUS-B-FNA是诊断纵隔淋巴结病的一种有用的辅助工具。与EBUS-TBNA联合应用时,它具有相当好的诊断率,并且在EBUS-TBNA不可行的情况下是一种很好的替代方法。